A Phase 2 Study of HQK-1001, an Oral Fetal Haemoglobin Inducer, in β-thalassaemia Intermedia
Overview
Authors
Affiliations
Current Standards of Care and Long Term Outcomes for Thalassemia and Sickle Cell Disease.
Chonat S, Quinn C Adv Exp Med Biol. 2017; 1013:59-87.
PMID: 29127677 PMC: 5720159. DOI: 10.1007/978-1-4939-7299-9_3.
Evolution of hemoglobin loci and their regulatory elements.
Philipsen S, Hardison R Blood Cells Mol Dis. 2017; 70:2-12.
PMID: 28811072 PMC: 5807248. DOI: 10.1016/j.bcmd.2017.08.001.
Ng N, Ko C Int Sch Res Notices. 2016; 2014:123257.
PMID: 27350962 PMC: 4897541. DOI: 10.1155/2014/123257.
Chou Y, Chen R, Lai Z, Song J, Chao Y, Shen C Mol Cell Biol. 2015; 35(14):2541-53.
PMID: 25986606 PMC: 4475914. DOI: 10.1128/MCB.00035-15.